Search the Archive

Medicine: Osteoporosis Drug #859105

CBS Evening News for Wednesday, May 02, 2007
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Katie Couric) National Osteoporosis Foundation statistics on Americans with osteoporosis cited.

(Studio: Jon LaPook) "New England Journal of Medicine" study findings on a new once-a-year medication {zoledronic acid†} to treat osteoporosis examined; details given about the medical complications from hip fracture and about how the drug reduces fractures. [Osteoporosis patient Midge HACKMAN - praises the new drug.] [Helen Hayes Hospital Dr. Felicia COSMAN†- comments on the drug's effectiveness.] [New York University Medical Center Dr. Steven GOLDSTEIN†- cites statistics on hip fracture patients.]

Couric, Katie;
LaPook, Jon

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.